
CC
USDChemours Company (The) Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$11.820
High
$12.040
Low
$11.620
Volume
3.74M
Company Fundamentals
Market Cap
1.8B
Industry
Specialty Chemicals
Country
United States
Trading Stats
Avg Volume
3.92M
Exchange
NYQ
Currency
USD
52-Week Range
AI Analysis Report
Last updated: May 26, 2025CC: Chemours Company – Navigating News, Price Swings, and Future Signals
Stock Symbol: CC Generate Date: 2025-05-26 05:12:28
Let's break down what's been happening with Chemours Company (CC) and what the tea leaves might be telling us.
Recent News Buzz: A Mixed Bag
The news flow for Chemours lately has been a bit of a mixed picture, leaning towards caution from the analyst community, but with some interesting business developments.
On the positive side, Chemours is clearly pushing into the AI data center space. We saw two announcements about liquid cooling solutions: one with DataVolt (May 19th) and another with Navin Fluorine (May 6th). This is a smart move, aiming to tap into the massive demand for efficient cooling as AI infrastructure grows. It shows the company is innovating and looking for new revenue streams. Plus, the broader news about the US fast-tracking mining projects (May 2nd) could indirectly benefit Chemours if it boosts demand for specialty chemicals in related industries.
However, the analyst sentiment has been a bit of a downer. Both Goldman Sachs (May 14th) and RBC Capital (May 8th) maintained their "Neutral" and "Outperform" ratings, respectively, but lowered their price targets to $14. This suggests they see less immediate upside than before. The company also reported its Q1 2025 results on May 6th, which likely influenced these target adjustments.
So, the vibe is: good long-term strategic moves, but analysts are tempering expectations in the short term.
Price Check: A Rocky Ride Down
Looking at the last 30 days of trading, CC has been on a noticeable downtrend. Back in late February, it was trading around $15-$16. Fast forward to early April, and we saw a sharp drop, with the stock hitting its 52-week low of $9.33 on April 9th. While it bounced back a bit into the $11-$12 range through late April and early May, the overall trend since late February has been clearly downward.
The most recent trading day (May 23rd) closed at $10.30. This is quite a bit lower than where it was just a few months ago. The average trading volume is around 3.67 million shares, but we've seen some days with much higher volume, like the 28.5 million on March 21st, which often signals significant shifts.
Now, for the AI's take on the immediate future:
- Today's Prediction: 0.05% change
- Next Day's Prediction: 0.01% change
- The Day after next day's Prediction: 0.11% change
These predictions suggest very minor upward movements in the very near term, almost flat. This contrasts with the recent downward trend, implying the AI doesn't see a continuation of the sharp declines, but also no strong rebound right away.
Outlook & Ideas: A Cautious Look at Opportunity
Putting it all together, the situation for Chemours seems to be one where caution is warranted, but there might be an interesting setup for aggressive, short-term traders.
The analyst downgrades on price targets, despite the positive long-term strategic news, have clearly weighed on the stock. The price action confirms this, showing a significant decline from earlier levels. However, the stock is currently trading very close to its 52-week low and the AI's predictions are for slight positive movement, not further drops.
AIPredictStock.com's analysis points to an "Oversold Opportunity" with a "recommend score" of 50.67 and "confidence" of 62.02. This is driven by a few key technical signals:
- RSI at 24.6: This is a classic "oversold" signal, meaning the stock might have fallen too far, too fast, and could be due for a bounce.
- Current Price near support ($10.36): The stock is hovering right around a level where it might find buying interest.
- OBV Surge: A massive spike in trading volume (16.5x average) suggests strong buying pressure recently, which is a positive sign.
On the flip side, there are some fundamental concerns: a high P/E ratio (57.2x), low revenue growth (0.4%), low Return on Equity (4.2%), and very high debt (Debt-to-Equity at 755.35%). These are red flags for long-term fundamental investors. The MACD also shows a bearish crossover.
So, what does this mean for potential action?
- Apparent Near-Term Leaning: Given the oversold technicals and the AI's slightly positive short-term outlook, the situation might favor aggressive buyers looking for a short-term bounce, rather than a sustained upward trend. It's definitely not a "strong buy and hold" signal based on fundamentals.
- Potential Entry Consideration: For those comfortable with higher risk and a short-term horizon, an entry could be considered around the current price of $10.30, or on any slight dip towards the $10.33-$10.42 range identified by the recommendation. The idea here is to capitalize on a potential bounce from oversold conditions.
- Potential Exit/Stop-Loss Consideration: If you're thinking about a short-term trade, a take-profit target around $10.50 seems reasonable, aligning with the recommendation data. This is a quick profit target. Crucially, a stop-loss is vital here. Placing it below the recent 52-week low, perhaps around $9.26, would be a smart move to limit potential losses if the stock continues its downward slide despite the oversold signals. Remember, the DMI still shows a bearish trend.
Company Context
It's important to remember that Chemours is a global chemistry company. They're involved in everything from refrigerants and thermal solutions (where the AI data center news fits in) to titanium dioxide pigments and advanced performance materials. Their core business is tied to industrial demand and broader economic health. The push into AI cooling is a strategic diversification, but their overall performance will still be heavily influenced by their traditional segments. The high debt level is a significant factor to keep in mind for any long-term view.
Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Investing in stocks involves risks, and you could lose money. Always conduct your own thorough research and consult with a qualified financial professional before making any investment decisions. The predictions from the AI model are based on historical data and algorithms and are not guarantees of future performance.
Related News
Chemours Appoints Industry Vet Nathan Blom as Vice President of Liquid Cooling Growth Portfolio
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company, announced the appointment of Nathan Blom as Vice President of its liquid cooling portfolio, effective June 9, 2025. With Blom's wealth of
Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $13
Barclays analyst Michael Leithead maintains Chemours with a Equal-Weight and lowers the price target from $16 to $13.
AI PredictionBeta
AI Recommendation
Updated at: Jun 12, 2025, 12:02 PM
64.5% Confidence
Risk & Trading
Entry Point
$11.78
Take Profit
$12.70
Stop Loss
$10.67
Key Factors
Related Stocks

LVLU
Lulu's Fashion Lounge Holdings Inc.

EAD
Allspring Income Opportunities Fund Common Shares

BXMT
Blackstone Mortgage Trust Inc.

LOGI
Logitech International S.A. Ordinary Shares

RDZNW
Roadzen Inc. Warrants
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.